NATROX® Wound Care is an Inotec AMD brand. The specialist wound care company was formed specifically to introduce new technologies to healthcare professionals around the world to promote faster and better healing for patients. The company’s flagship product, NATROX® Oxygen Wound Therapy, is positioned to become integral to wound care treatment regimes in the coming years. As a Federal Supply Schedule contract holder, NATROX® Therapy helps address the devastating impact of chronic wounds on Veterans’ lives. Recent RCT results demonstrate 71% greater healing and 73% greater reduction in wound size for NATROX® O2 treated patients1. The discreet, lightweight, wearable device allows patients full mobility while actively maintaining therapy 24/7, causing minimal disruption to the patient’s lifestyle. Its simple design makes it easy to use in both clinical and home care settings. In addition, NATROX® Wound Care recently launched its newest offering, NATROX® IQ in Hong Kong and Malaysia. The advanced digital platform helps clinicians with managing their wound care caseloads more effectively. The cloud-based hub enables clinical teams across various locations and disciplines to capture and access up-to-date information on wound care patients. The platform connects to a third-party software that leverages the power of AI to digitally measure wound size and depth. It even allows clinicians to oversee wound progression remotely via a telehealth feature which can help reduce non-essential clinic visits. NATROX® IQ is in the development stages of being available in the US. 1) Read the RCT on our website: https://www.natroxwoundcare.com/resources/